ID   MK09_RAT                Reviewed;         423 AA.
AC   P49186;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   02-OCT-2024, entry version 191.
DE   RecName: Full=Mitogen-activated protein kinase 9;
DE            Short=MAP kinase 9;
DE            Short=MAPK 9;
DE            EC=2.7.11.24 {ECO:0000269|PubMed:10856240};
DE   AltName: Full=SAPK-alpha;
DE   AltName: Full=Stress-activated protein kinase JNK2;
DE   AltName: Full=c-Jun N-terminal kinase 2;
DE   AltName: Full=p54-alpha;
GN   Name=Mapk9; Synonyms=Jnk2, Prkm9;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS ALPHA-1 AND ALPHA-2), AND PARTIAL
RP   PROTEIN SEQUENCE.
RC   TISSUE=Brain;
RX   PubMed=8177321; DOI=10.1038/369156a0;
RA   Kyriakis J.M., Banerjee P., Nikolakaki E., Dai T., Rubie E.A., Ahmad M.F.,
RA   Avruch J., Woodgett J.R.;
RT   "The stress-activated protein kinase subfamily of c-Jun kinases.";
RL   Nature 369:156-160(1994).
RN   [2]
RP   INTERACTION WITH MECOM, AND CATALYTIC ACTIVITY.
RX   PubMed=10856240; DOI=10.1093/emboj/19.12.2958;
RA   Kurokawa M., Mitani K., Yamagata T., Takahashi T., Izutsu K., Ogawa S.,
RA   Moriguchi T., Nishida E., Yazaki Y., Hirai H.;
RT   "The evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents
RT   stress-induced cell death.";
RL   EMBO J. 19:2958-2968(2000).
CC   -!- FUNCTION: Serine/threonine-protein kinase involved in various processes
CC       such as cell proliferation, differentiation, migration, transformation
CC       and programmed cell death. Extracellular stimuli such as pro-
CC       inflammatory cytokines or physical stress stimulate the stress-
CC       activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling
CC       pathway. In this cascade, two dual specificity kinases MAP2K4/MKK4 and
CC       MAP2K7/MKK7 phosphorylate and activate MAPK9/JNK2. In turn, MAPK9/JNK2
CC       phosphorylates a number of transcription factors, primarily components
CC       of AP-1 such as JUN and ATF2 and thus regulates AP-1 transcriptional
CC       activity. In response to oxidative or ribotoxic stresses, inhibits rRNA
CC       synthesis by phosphorylating and inactivating the RNA polymerase 1-
CC       specific transcription initiation factor RRN3. Promotes stressed cell
CC       apoptosis by phosphorylating key regulatory factors including TP53 and
CC       YAP1. In T-cells, MAPK8 and MAPK9 are required for polarized
CC       differentiation of T-helper cells into Th1 cells. Upon T-cell receptor
CC       (TCR) stimulation, is activated by CARMA1, BCL10, MAP2K7 and
CC       MAP3K7/TAK1 to regulate JUN protein levels. Plays an important role in
CC       the osmotic stress-induced epithelial tight-junctions disruption. When
CC       activated, promotes beta-catenin/CTNNB1 degradation and inhibits the
CC       canonical Wnt signaling pathway. Participates also in neurite growth in
CC       spiral ganglion neurons. Phosphorylates the CLOCK-BMAL1 heterodimer and
CC       plays a role in the regulation of the circadian clock (By similarity).
CC       Phosphorylates POU5F1, which results in the inhibition of POU5F1's
CC       transcriptional activity and enhances its proteasomal degradation (By
CC       similarity). Phosphorylates ALKBH5 in response to reactive oxygen
CC       species (ROS), promoting ALKBH5 sumoylation and inactivation (By
CC       similarity). {ECO:0000250|UniProtKB:P45984,
CC       ECO:0000250|UniProtKB:Q9WTU6}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.24;
CC         Evidence={ECO:0000269|PubMed:10856240};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.24; Evidence={ECO:0000269|PubMed:10856240};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:P45984};
CC   -!- ACTIVITY REGULATION: Activated by threonine and tyrosine
CC       phosphorylation by either of two dual specificity kinases, MAP2K4 and
CC       MAP2K7. MAP2K4 shows a strong preference for Tyr-185 while MAP2K7
CC       phosphorylates Tyr-183 preferentially. Inhibited by dual specificity
CC       phosphatases, such as DUSP1. {ECO:0000250|UniProtKB:P45984}.
CC   -!- SUBUNIT: Interacts with MECOM (PubMed:10856240). Binds to at least four
CC       scaffolding proteins, MAPK8IP1/JIP-1, MAPK8IP2/JIP-2, MAPK8IP3/JIP-
CC       3/JSAP1 and SPAG9/MAPK8IP4/JIP-4. These proteins also bind other
CC       components of the JNK signaling pathway (By similarity). Interacts with
CC       NFATC4 (By similarity). Interacts with ATF7; the interaction does not
CC       phosphorylate ATF7 but acts as a docking site for ATF7-associated
CC       partners such as JUN (By similarity). Interacts with BCL10 (By
CC       similarity). Interacts with CTNNB1 and GSK3B (By similarity). Interacts
CC       with DCLK2 (By similarity). Interacts with MAPKBP1 (By similarity).
CC       Interacts with POU5F1; phosphorylates POU5F1 at 'Ser-347'. Found in a
CC       complex with SH3RF1, RAC2, MAP3K7/TAK1, MAP2K7/MKK7, MAPK8IP1/JIP1 and
CC       MAPK8/JNK1 (By similarity). {ECO:0000250|UniProtKB:P45984,
CC       ECO:0000250|UniProtKB:Q9WTU6, ECO:0000269|PubMed:10856240}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P45984}. Nucleus
CC       {ECO:0000250|UniProtKB:Q9WTU6}. Note=Colocalizes with POU5F1 in the
CC       nucleus. {ECO:0000250|UniProtKB:Q9WTU6}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Alpha-2;
CC         IsoId=P49186-1; Sequence=Displayed;
CC       Name=Alpha-1;
CC         IsoId=P49186-2; Sequence=VSP_004838;
CC   -!- DOMAIN: The TXY motif contains the threonine and tyrosine residues
CC       whose phosphorylation activates the MAP kinases.
CC   -!- PTM: Dually phosphorylated on Thr-183 and Tyr-185 by MAP2K7 and MAP2K4,
CC       which activates the enzyme. Autophosphorylated in vitro.
CC       {ECO:0000250|UniProtKB:P45984}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC Ser/Thr
CC       protein kinase family. MAP kinase subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L27112; AAA42109.1; -; mRNA.
DR   EMBL; L27111; AAA42108.1; -; mRNA.
DR   PIR; S43968; S43968.
DR   RefSeq; NP_001257473.1; NM_001270544.1.
DR   RefSeq; NP_059018.1; NM_017322.2. [P49186-1]
DR   AlphaFoldDB; P49186; -.
DR   SMR; P49186; -.
DR   BioGRID; 248408; 1.
DR   IntAct; P49186; 2.
DR   MINT; P49186; -.
DR   STRING; 10116.ENSRNOP00000004010; -.
DR   iPTMnet; P49186; -.
DR   PhosphoSitePlus; P49186; -.
DR   jPOST; P49186; -.
DR   PaxDb; 10116-ENSRNOP00000003987; -.
DR   GeneID; 50658; -.
DR   KEGG; rno:50658; -.
DR   UCSC; RGD:628847; rat. [P49186-1]
DR   AGR; RGD:628847; -.
DR   CTD; 5601; -.
DR   RGD; 628847; Mapk9.
DR   eggNOG; KOG0665; Eukaryota.
DR   InParanoid; P49186; -.
DR   OrthoDB; 158564at2759; -.
DR   PhylomeDB; P49186; -.
DR   BRENDA; 2.7.11.24; 5301.
DR   Reactome; R-RNO-2559580; Oxidative Stress Induced Senescence.
DR   Reactome; R-RNO-2871796; FCERI mediated MAPK activation.
DR   Reactome; R-RNO-450321; JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1.
DR   Reactome; R-RNO-450341; Activation of the AP-1 family of transcription factors.
DR   PRO; PR:P49186; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; IDA:MGI.
DR   GO; GO:0005739; C:mitochondrion; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0043204; C:perikaryon; IDA:RGD.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IDA:RGD.
DR   GO; GO:0008656; F:cysteine-type endopeptidase activator activity involved in apoptotic process; IMP:RGD.
DR   GO; GO:0004705; F:JUN kinase activity; IDA:RGD.
DR   GO; GO:0031435; F:mitogen-activated protein kinase kinase kinase binding; IPI:RGD.
DR   GO; GO:0004672; F:protein kinase activity; ISO:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISO:RGD.
DR   GO; GO:0004712; F:protein serine/threonine/tyrosine kinase activity; ISO:RGD.
DR   GO; GO:0097190; P:apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0071474; P:cellular hyperosmotic response; IEP:RGD.
DR   GO; GO:1904646; P:cellular response to amyloid-beta; IEP:RGD.
DR   GO; GO:0071276; P:cellular response to cadmium ion; ISO:RGD.
DR   GO; GO:0071363; P:cellular response to growth factor stimulus; IEP:RGD.
DR   GO; GO:0071347; P:cellular response to interleukin-1; IEP:RGD.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0034614; P:cellular response to reactive oxygen species; ISO:RGD.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IEP:RGD.
DR   GO; GO:0034644; P:cellular response to UV; IMP:RGD.
DR   GO; GO:0090594; P:inflammatory response to wounding; ISO:RGD.
DR   GO; GO:0007254; P:JNK cascade; IDA:RGD.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0048666; P:neuron development; IEP:RGD.
DR   GO; GO:0031175; P:neuron projection development; IMP:RGD.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IMP:RGD.
DR   GO; GO:2001235; P:positive regulation of apoptotic signaling pathway; ISO:RGD.
DR   GO; GO:0045597; P:positive regulation of cell differentiation; IMP:RGD.
DR   GO; GO:0032722; P:positive regulation of chemokine production; IMP:RGD.
DR   GO; GO:1900017; P:positive regulation of cytokine production involved in inflammatory response; ISO:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; IMP:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0010744; P:positive regulation of macrophage derived foam cell differentiation; ISO:RGD.
DR   GO; GO:0045429; P:positive regulation of nitric oxide biosynthetic process; IMP:RGD.
DR   GO; GO:0051770; P:positive regulation of nitric-oxide synthase biosynthetic process; IMP:RGD.
DR   GO; GO:0071803; P:positive regulation of podosome assembly; ISO:RGD.
DR   GO; GO:0031394; P:positive regulation of prostaglandin biosynthetic process; IMP:RGD.
DR   GO; GO:0032308; P:positive regulation of prostaglandin secretion; IMP:RGD.
DR   GO; GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; ISO:RGD.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IMP:RGD.
DR   GO; GO:0031398; P:positive regulation of protein ubiquitination; ISO:RGD.
DR   GO; GO:0061833; P:protein localization to tricellular tight junction; ISO:RGD.
DR   GO; GO:0006626; P:protein targeting to mitochondrion; IEP:RGD.
DR   GO; GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB.
DR   GO; GO:0046328; P:regulation of JNK cascade; IMP:RGD.
DR   GO; GO:0031396; P:regulation of protein ubiquitination; IMP:RGD.
DR   GO; GO:0001836; P:release of cytochrome c from mitochondria; IMP:RGD.
DR   GO; GO:0014075; P:response to amine; IEP:RGD.
DR   GO; GO:0046686; P:response to cadmium ion; ISO:RGD.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEP:RGD.
DR   GO; GO:1990089; P:response to nerve growth factor; IEP:RGD.
DR   GO; GO:0009636; P:response to toxic substance; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IMP:RGD.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   CDD; cd07850; STKc_JNK; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR050117; MAP_kinase.
DR   InterPro; IPR003527; MAP_kinase_CS.
DR   InterPro; IPR008351; MAPK_JNK.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   PANTHER; PTHR24055; MITOGEN-ACTIVATED PROTEIN KINASE; 1.
DR   PANTHER; PTHR24055:SF172; MITOGEN-ACTIVATED PROTEIN KINASE 9; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   PRINTS; PR01772; JNKMAPKINASE.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS01351; MAPK; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Biological rhythms; Cytoplasm;
KW   Direct protein sequencing; Kinase; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Serine/threonine-protein kinase;
KW   Transferase.
FT   CHAIN           1..423
FT                   /note="Mitogen-activated protein kinase 9"
FT                   /id="PRO_0000186275"
FT   DOMAIN          26..321
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          366..423
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           183..185
FT                   /note="TXY"
FT   COMPBIAS        374..415
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        151
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         32..40
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         55
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         183
FT                   /note="Phosphothreonine; by MAP2K7"
FT                   /evidence="ECO:0000250|UniProtKB:P45984"
FT   MOD_RES         185
FT                   /note="Phosphotyrosine; by MAP2K4"
FT                   /evidence="ECO:0000250|UniProtKB:P45984"
FT   VAR_SEQ         216..230
FT                   /note="GELVKGCVIFQGTDH -> AEMVLHKSCSPGRDY (in isoform
FT                   Alpha-1)"
FT                   /evidence="ECO:0000303|PubMed:8177321"
FT                   /id="VSP_004838"
SQ   SEQUENCE   423 AA;  48017 MW;  EE549B9F4F12F421 CRC64;
     MSDSKSDGQF YSVQVADSTF TVLKRYQQLK PIGSGAQGIV CAAFDTVLGI NVAVKKLSRP
     FQNQTHAKRA YRELVLLKCV NHKNIISLLN VFTPQKTLEE FQDVYLVMEL MDANLCQVIH
     MELDHERMSY LLYQMLCGIK HLHSAGIIHR DLKPSNIVVK SDCTLKILDF GLARTACTNF
     MMTPYVVTRY YRAPEVILGM GYKENVDIWS VGCIMGELVK GCVIFQGTDH IDQWNKVIEQ
     LGTPSAEFMK KLQPTVRNYV ENRPKYPGIK FEELFPDWIF PSESERDKIK TSQARDLLSK
     MLVIDPDKRI SVDEALRHPY ITVWYDPAEA EAPPPQIYDA QLEEREHAIE EWKELIYKEV
     MDWEERSKNG VKDQPSDAAV SSKATPSQSS SINDISSMST EHTLASDTDS SLDASTGPLE
     GCR
//
